old
world
frugivor
bat
genu
pteropu
famili
pteropodida
reservoir
import
zoonot
paramyxovirus
includ
nipah
viru
hendra
viru
member
genu
henipaviru
famili
paramyxovirida
hendra
nipah
virus
associ
sever
neurolog
respiratori
diseas
high
mortal
rate
domest
anim
human
hendra
viru
enzoot
pteropid
bat
australia
nipah
nipahlik
virus
identifi
pteropu
speci
throughout
asia
relat
pteropodid
bat
speci
africa
field
laboratori
studi
conduct
elucid
viral
dynam
pteropid
bat
order
better
understand
time
natur
spillov
human
henipavirus
appear
acut
shed
period
bat
experiment
natur
infect
pteropid
bat
result
viral
rna
detect
excreta
day
post
infect
isol
within
week
appar
infect
respect
make
detect
infect
individu
wild
challeng
result
field
studi
larg
reli
serolog
data
identifi
infect
rate
free
rang
bat
popul
serolog
studi
nipah
hendra
viru
antibodi
freerang
pteropid
bat
coloni
found
seropreval
high
howev
viral
isol
molecular
studi
suggest
low
incid
infect
serum
neutral
test
snt
consid
gold
standard
detect
specif
antibodi
hendra
nipah
viru
howev
use
snt
limit
particularli
countri
henipavirus
enzoot
classifi
select
agent
requir
highest
level
biocontain
biosafeti
level
bsl
order
work
live
viral
cultur
requir
conduct
neutral
assay
bsl
lab
avail
countri
henipavirus
occur
igg
enzymelink
immunosorb
assay
elisa
luminex
assay
use
test
sera
antinipah
antihendra
antibodi
perform
standard
biosafeti
condit
use
serolog
studi
understand
dynam
infecti
agent
wildlif
present
challeng
serolog
assay
valid
wildlif
speci
antibodi
may
cross
react
crossneutr
relat
viral
antigen
limit
specif
assay
also
littl
inform
avail
matern
transfer
immun
pteropid
bat
includ
long
specif
antibodi
remain
pup
blood
make
difficult
studi
wild
bat
determin
precis
anim
infect
whether
subadult
may
still
residu
matern
immun
bat
gener
undergo
hemochori
placent
similar
repertoir
immunoglobulin
subclass
iga
ige
igg
igm
placent
mammal
like
transfer
matern
antibodi
utero
like
human
nonhuman
primat
addit
bat
found
higher
genet
divers
variabl
heavi
chain
gene
region
antibodi
repertoir
compar
mammal
transmiss
matern
immun
mother
offspr
occur
either
across
placenta
mammari
gland
littl
known
gener
pteropu
immunolog
structur
gamma
immunoglobulin
igg
pteropodid
bat
appear
consist
eutherian
mammal
transfer
matern
antibodi
observ
captiv
pteropid
bat
though
primari
mechan
describ
pteropid
bat
speci
examin
date
placenta
hemodichori
structur
similar
human
rabbit
type
placent
particip
activ
transfer
igg
utero
detect
antibodi
menangl
viru
menv
fetus
pteropu
poliocephalu
dam
seroposit
menv
support
transplacent
transfer
matern
antibodi
pteropid
bat
pteropu
alecto
bat
high
abund
igg
milk
featur
gener
associ
speci
transfer
matern
immun
via
colostrum
offspr
thu
possibl
bat
capabl
transfer
igg
transplacent
across
mammari
gland
differ
kinet
antibodi
respons
report
bat
compar
convent
laboratori
anim
review
antibodi
appear
play
role
viral
immun
observ
bat
vaccin
rabi
viru
compar
unvaccin
anim
succumb
diseas
role
igg
antibodi
henipaviru
infect
pteropu
spp
less
certain
infect
bat
may
measur
titer
infect
bat
may
shed
viru
despit
measur
titer
hendra
viru
antibodi
found
pteropu
conspicillatu
pup
twosix
week
old
born
seroposit
dam
titer
proportion
dam
agestratifi
analys
juvenil
seropreval
may
help
elucid
viral
incid
provid
anim
age
accur
assess
studi
captiv
pteropu
vampyru
measur
matern
antibodi
month
postparturit
agestratifi
survey
hendra
viru
littl
red
fli
fox
pteropu
scapulatu
australia
found
adult
bat
hev
seropreval
approxim
prewean
individu
seropreval
n
juvenil
seropreval
could
indic
recent
viral
circul
within
bat
coloni
presenc
matern
igg
may
confound
seroepidemiolog
studi
interpret
serolog
data
juvenil
bat
challeng
durat
matern
igg
pup
unknown
difficult
accur
determin
age
juvenil
pteropid
bat
independ
dam
yet
sexual
matur
month
depend
speci
durat
matern
antibodi
describ
human
domest
anim
littl
data
avail
halflif
durat
matern
antibodi
pteropid
bat
longitudin
serolog
studi
hendra
viru
antibodi
p
scapulatu
measur
decreas
antibodi
wild
caught
juvenil
month
due
biosafeti
requir
henipavirus
associ
cost
run
experi
bsl
condit
experiment
infect
conduct
bat
none
conduct
measur
durat
matern
antibodi
henipavirus
pup
describ
two
complementari
studi
design
determin
durat
halflif
matern
antibodi
key
bat
reservoir
speci
henipavirus
p
hypomelanu
reservoir
nipah
viru
p
alecto
primari
reservoir
hendra
viru
first
experi
vaccin
member
captiv
breed
popul
p
hypomelanu
use
viral
antigen
close
relat
nipah
viru
would
allow
us
measur
durat
matern
antibodi
offspr
bsl
condit
second
experi
measur
durat
matern
antibodi
hendra
viru
pup
born
natur
infect
dam
captiv
coloni
p
alecto
work
conduct
lube
bat
conserv
gainesvil
florida
iacuc
epstein
twenti
adult
femal
pteropu
hypomelanu
introduc
two
male
captiv
breed
condit
period
week
male
remov
enclosur
femal
check
pregnanc
everi
month
use
ultrasound
none
bat
experi
previous
expos
vaccin
canin
distemp
viru
bat
also
test
neg
igg
antibodi
nipah
viru
center
diseas
control
prevent
unpublish
data
pregnant
femal
identifi
within
month
mate
separ
cohort
five
pregnant
bat
vaccin
canin
distemp
viru
use
canarypoxvector
canin
distemp
viru
vaccin
meriel
usa
accord
manufactur
instruct
dog
previous
demonstr
dose
regimen
elicit
immun
respons
p
hypomelanu
unpublish
data
nine
bat
studi
group
pregnant
nonpregn
control
group
bat
nonmat
given
ml
vaccin
subcutan
day
begin
third
month
gestat
ml
blood
drawn
bat
prior
day
establish
neg
titer
blood
drawn
day
initi
dose
everi
day
end
studi
blood
sampl
ml
collect
either
radial
arteryvein
saphen
vein
use
g
needl
adult
ml
tuberculin
syring
juvenil
born
vaccin
mother
everi
day
month
neg
titer
obtain
sampl
began
pup
minimum
weight
g
approxim
week
age
sampl
continu
receiv
titer
point
consid
titer
neg
dog
protect
titer
consid
cornel
veterinari
diagnost
lab
howev
date
experiment
challeng
cdv
bat
speci
lab
heattreat
plasma
sampl
accord
standard
practic
allow
activ
complement
nonspecif
neutral
viru
dilut
therefor
consid
titer
neg
cutoff
studi
blood
place
edta
tube
vaccutain
bd
usa
ml
plasma
sent
anim
health
diagnost
center
cornel
univers
ithaca
ny
measur
neutral
antibodi
cdv
use
neutral
test
briefli
dilut
plasma
per
well
ad
well
microtit
plate
contain
equal
volum
test
medium
serial
dilut
done
end
plate
equal
volum
cdv
onderstepoort
strain
contain
viru
ad
well
plate
incub
least
hr
vero
cell
ad
suspens
well
cell
per
well
plate
incub
five
day
well
examin
presenc
typic
cdv
cytopatholog
well
score
posit
neg
titer
plasma
reciproc
dilut
calcul
end
point
work
conduct
csiro
australian
anim
health
laboratori
aahl
geelong
victoria
work
approv
aahl
anim
ethic
committe
protocol
pteropu
alecto
captur
environ
brisban
queensland
use
mist
net
bat
caught
held
queensland
epa
scientif
permit
victorian
dept
primari
industri
dpi
scientif
permit
bat
import
victoria
queensland
victorian
dpi
import
permit
thirteen
adult
femal
bat
determin
pregnant
abdomin
palpat
brought
captiv
aahl
august
thirteen
bat
gave
birth
singl
pup
late
octob
earli
novemb
urin
oropharyng
swab
specimen
adult
neonat
bat
use
experi
screen
neg
hendra
viru
rna
use
rt
pcr
data
shown
adult
femal
allow
acclimat
period
one
week
follow
transfer
captiv
sampl
obtain
pup
sampl
one
month
postpartum
blood
collect
adult
pup
everi
day
month
postpartum
adult
anim
anaesthet
use
isofluran
ga
anesthet
ml
blood
obtain
cephal
vein
use
g
needl
pup
bled
cephal
vein
use
g
needl
attach
multivett
tube
sarstedt
ml
blood
obtain
monthli
one
month
month
postpartum
blood
place
serum
collect
tube
vaccutain
bd
usa
sera
heat
inactiv
minut
prior
use
sera
test
antibodi
bind
recombin
solubl
hendra
viru
g
glycoprotein
sghev
use
luminex
multiplex
bind
assay
describ
previous
briefli
sghev
coupl
microspher
biorad
laboratori
inc
incub
sera
follow
incub
biotynyl
protein
ag
pierc
rockford
il
usa
follow
streptavidinphycoerythrin
qiagen
doncast
vic
australia
antibodi
bound
sghev
coat
bead
quantifi
fluoresc
read
median
fluoresc
intens
mfi
bioplex
protein
array
system
integr
bioplex
manag
softwar
biorad
laboratori
inc
ca
usa
mfi
valu
consid
neg
order
confirm
luminex
result
serum
neutral
test
snt
perform
subset
sampl
pup
g
g
select
time
point
four
adult
describ
previous
use
start
serum
dilut
serum
neutral
determin
presenc
cytopath
effect
cpe
cellular
monolay
record
serum
dilut
cpe
evid
experi
util
live
viru
perform
bsl
condit
antibodi
decay
rate
calcul
use
twocompartment
model
base
initi
distribut
phase
describ
equilibr
biolog
agent
intra
extravascular
space
termin
phase
elimin
repres
actual
use
materi
phase
describ
fit
independ
linear
model
method
also
allow
determin
confid
interv
assess
model
adequaci
eg
inde
two
phase
biphas
decay
rate
detect
termin
halflif
use
repres
rate
antibodi
decay
halfliv
estim
fit
nonparametr
regress
analys
perform
use
statist
softwar
r
packag
pk
mean
durat
immun
group
compar
use
unpair
student
ttest
physicscsbsjueducgibinstatsttest
pup
titer
compar
use
welch
test
statist
softwar
r
adult
bat
show
immun
respons
canin
distemp
vaccin
figur
five
p
hypomelanu
pup
born
vaccin
dam
initi
termin
halfliv
repres
first
second
phase
biexponenti
antibodi
decay
calcul
pup
present
tabl
two
pup
could
use
halflif
calcul
drop
neg
cutoff
fewer
four
titer
measur
minimum
requir
halflif
calcul
two
pup
cahya
chesa
twin
belong
charisma
start
titer
mean
n
significantli
lower
three
pup
mean
welch
df
p
three
remain
pup
show
biphas
cdv
antibodi
halfliv
titer
curv
pup
present
figur
geometr
mean
gm
initi
halflif
day
ci
gm
termin
halflif
day
ci
mean
durat
immun
titer
n
day
ci
month
initi
antihendra
viru
antibodi
titer
adult
p
alecto
titer
immedi
preced
parturit
shown
figur
serum
antibodi
titer
sampl
collect
close
birth
pup
display
similar
level
hevsg
antibodi
detect
follow
captur
twelv
pup
born
seroposit
dam
serum
antibodi
recombin
hev
sg
one
pup
pup
born
seroneg
dam
also
seroneg
data
shown
titer
curv
pup
one
twelv
month
postpartum
also
present
figur
compar
purpos
snt
perform
pup
g
demonstr
presenc
neutral
antibodi
hev
data
shown
initi
termin
halflif
twelv
seroposit
pup
shown
tabl
twelv
pup
two
appear
biphas
halfliv
wherea
initi
halfliv
equal
termin
halfliv
indic
monophas
decay
rate
geometr
mean
initi
phase
day
ci
geometr
mean
termin
phase
day
ci
mean
durat
immun
n
bat
day
ci
month
four
pup
studi
reach
neg
cutoff
within
timefram
studi
omit
calcul
mean
durat
immun
signific
differ
mean
durat
immun
experi
p
bat
becom
subject
increas
number
fieldbas
epidemiolog
studi
due
associ
zoonot
pathogen
ebola
viru
marburg
viru
nipah
viru
hendra
viru
sar
coronaviru
recent
novel
bat
coronaviru
middl
caus
mortal
human
suggest
outbreak
virus
within
bat
popul
relat
wane
immun
juvenil
cohort
understand
durat
matern
antibodi
pteropid
bat
age
bat
help
determin
whether
antihenipaviru
igg
juvenil
maternallyderiv
rather
result
viral
exposur
two
experi
present
provid
valuabl
data
relat
bat
immunolog
howev
limit
interpret
observ
differ
similar
result
two
experi
sinc
involv
differ
bat
speci
differ
methodolog
experi
use
canarypox
vector
canin
distemp
viru
vaccin
proxi
nipah
viru
infect
although
safest
option
may
gener
result
abl
follow
pup
born
p
hypomelanu
dam
natur
infect
niv
hev
experi
sinc
complet
experi
canarypox
vector
hendra
viru
vaccin
develop
may
serv
better
surrog
futur
studi
requir
lower
biosafeti
condit
expect
result
experi
base
natur
infect
pteropid
bat
hendra
viru
like
compar
immun
dynam
close
relat
speci
infect
nipah
viru
compar
experi
though
studi
provid
control
opportun
measur
immun
system
dynam
key
henipaviru
reservoir
speci
previou
agestratifi
serolog
studi
henipavirus
pteropid
bat
found
serostatu
neonat
match
dam
plowright
et
al
describ
annual
occurr
hev
spillov
event
australia
coincid
presenc
suscept
juvenil
popul
bat
estim
matern
antibodi
wane
approxim
month
postpartum
coincid
annual
hev
spillov
event
similarli
distinct
puls
marburg
viru
transmiss
juvenil
rousettu
aegyptiacu
fruit
bat
approxim
month
postpartum
report
wave
viru
infect
also
detect
myoti
myoti
bat
approxim
one
month
parturit
author
specul
may
associ
wane
matern
antibodi
studi
nipah
viru
captiv
p
vampyru
found
matern
igg
last
approxim
month
howev
exact
age
pup
studi
uncertain
two
four
die
titer
becam
neg
found
calcul
halflif
valu
matern
deriv
antibodi
differ
significantli
pup
vaccin
bat
experi
natur
infect
bat
experi
experi
four
pup
whose
titer
fall
neg
threshold
period
measur
omit
calcul
howev
endpoint
includ
mean
durat
immun
would
lengthen
although
determin
would
creat
statist
signific
differ
experi
bat
experi
show
similar
durat
matern
antibodi
month
experi
respect
durat
matern
immun
influenc
multipl
factor
includ
magnitud
mother
titer
gestat
affect
vaccin
vs
natur
infect
age
neonat
parturit
prematur
offspr
tend
receiv
fewer
antibodi
well
antibodi
decay
rate
neonat
durat
matern
antibodi
measl
viru
human
infant
shown
longer
born
natur
infect
mother
versu
mother
vaccin
timefram
observ
longer
suggest
six
month
estim
popul
level
hendra
viru
p
scapulatu
howev
data
experi
show
signific
decreas
titer
six
month
repres
approxim
termin
halflif
period
hendra
viru
antibodi
decay
less
start
titer
may
result
suffici
decreas
herd
immun
popul
level
allow
viral
circul
among
juvenil
cohort
direct
correl
observ
seroposit
dam
pup
antibodi
cdv
detect
five
pup
born
vaccin
dam
antihev
antibodi
detect
pup
born
seroposit
dam
hev
antibodi
one
pup
born
seroneg
dam
result
consist
earlier
hendra
viru
studi
demonstr
strong
associ
dam
pup
serostatu
appear
data
pup
titer
correl
dam
interestingli
found
charisma
lowest
titer
dam
produc
twin
chesa
cayha
significantli
lower
titer
peer
hypothes
correl
titer
dam
pup
howev
case
enough
data
test
statist
titer
chesa
cahya
independ
would
like
skew
correl
coeffici
toward
signific
measur
decay
rate
antibodi
adult
bat
howev
would
expect
slower
observ
pup
faster
decay
matern
deriv
antibodi
report
human
infant
born
vaccin
mother
compar
natur
immun
mother
henipavirus
import
group
zoonot
virus
carri
pteropu
speci
understand
pteropid
immunolog
import
model
dynam
viral
infect
within
fli
fox
popul
wane
immun
henipavirus
juvenil
cohort
may
critic
time
outbreak
within
coloni
therefor
relat
risk
spillov
human
anim
studi
bat
immunolog
help
ecolog
studi
viral
pathogen
also
understand
bat
respond
viral
infect
